Cytek Biosciences closes Series C round

Fremont, California-based Cytek Biosciences Inc, a provider of flow cytometry solutions, has raised an undisclosed amount of Series C funding. Northern Light Venture Capital and 3E Bioventures led the round. In conjunction with the funding, Feng Deng, founder of Northern Lights Ventures, will join Cytek’s board of directors.

Source: Press Release